Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 15-29
Open Access | Times Cited: 330

Showing 26-50 of 330 citing articles:

Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study
Ngoc V Nguyen, Elisabet Svenungsson, Annica Dominicus, et al.
Lara D. Veeken (2024) Vol. 64, Iss. 1, pp. 117-125
Open Access | Times Cited: 5
Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment
Anastasia-Georgia Dedemadi, Christina Gkolfinopoulou, Dimitra Nikoleri, et al.
Lara D. Veeken (2024)
Open Access | Times Cited: 5
Impact of glucocorticoid dose on complete response, serious infections, and mortality during the initial therapy of lupus nephritis: A systematic review and meta‐analysis of the control arms of randomized controlled trials
Gabriel Figueroa‐Parra, María C Cuéllar-Gutiérrez, Mariana González‐Treviño, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 9, pp. 1408-1418
Closed Access | Times Cited: 5
The 2024 APLAR Consensus on the Management of Lupus Nephritis
Chi Chiu Mok, Ho So, Laniyati Hamijoyo, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access
Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
Lakshmi Prasanna Vaishnavi Kattamuri, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Rheumatology International (2025) Vol. 45, Iss. 1
Closed Access
Real-World Prevalence, Incidence and Management of Systemic Lupus Erythematosus in Germany: A Retrospective Claims Data Analysis
Tobias Alexander, Philipp Sewerin, Anja Strangfeld, et al.
Rheumatology and Therapy (2025)
Open Access
Lupus Nephritis and Chronic Kidney Disease: A Scoping Review
Selene Tse Yen Teoh, Desmond YH Yap, Susan Yung, et al.
Nephrology (2025) Vol. 30, Iss. 1
Open Access
Executive Summary of the 2024 Asia‐Pacific League of Associations for Rheumatology Consensus Statements on Lupus Nephritis Management
Desmond Y. H. Yap, Ho So, Laniyati Hamijoyo, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access
Safety, Tolerability, and Pharmacokinetics of NIM‐1324 an Oral LANCL2 Agonist in a Randomized, Double‐Blind, Placebo‐Controlled Phase I Clinical Trial
Andrew Leber, Raquel Hontecillas, Nuria Tubau‐Juni, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 1
Open Access
Novel therapies in SLE treatment: A literature review
Jakub Mastalerz, Alicja Dąbrowska, Wojciech Plizga, et al.
Advances in Clinical and Experimental Medicine (2025) Vol. 34, Iss. 11
Open Access
New Treatment Regimens, New Drugs, and New Treatment Goals for Lupus Nephritis
Giovanni Maria Rossi, Augusto Vaglio
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 584-584
Open Access
Efficacy of anifrolumab on systemic lupus erythematosus patients with serological manifestations: A post hoc analysis of the Japan subgroup of the TULIP-2 Trial
Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
Modern Rheumatology (2025)
Closed Access
Prognostic Factors of the Progression of Chronic Kidney Disease and the Development of End-Stage Renal Disease in Patients with Lupus Nephritis: A Retrospective Cohort Study
Bianka Perge, Gábor Papp, Bernadett Bói, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 665-665
Open Access
Lupus Nephritis: 10 questions to think about
Enrique Morales, María Galindo
Nefrología (English Edition) (2025)
Open Access
Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study
Soo‐Kyung Cho, Jung-Yong Han, Yena Jeon, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
Advances in Targeted Therapy for Systemic Lupus Erythematosus: Current Treatments and Novel Approaches
Kaoru Saegusa, Yumi Tsuchida, Toshihiko Komai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 929-929
Open Access
Organ-based characterization of B cells in patients with systemic lupus erythematosus
Yunan Wang, Rui Zhao, Qian Liang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Steroid-induced diabetes in lupus nephritis patients: Classic risk factors or a different type of diabetes?
Cristian Alejandro Dimas-Ramírez, Luis André Fortanell-Meza, Diego San Agustín-Morales, et al.
Lupus (2025)
Closed Access
Targeting Nanotherapeutics for Highly Efficient Diagnosis and Treatment of Systemic Lupus Erythematosus through Regulation of Immune Response
Ting Liu, Zhiming Lin, Xi Zhang, et al.
Small Science (2025)
Open Access
Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)
Martin Aringer, Laurent Arnaud, Richard Furie, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001336-e001336
Open Access
Risk and protective factors of disease flare during pregnancy in systemic lupus erythematosus: a systematic review and meta-analysis
Yudi Yang, Yangzhong Zhou, Xueyang Zhang, et al.
Clinical Rheumatology (2025)
Closed Access
Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis
Decimo Silvio Chiarenza, Raul Mancini, Carolina Bigatti, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
New insights into the long-term adverse effects of antimalarials in patients with systemic lupus erythematosus
Olga Araújo, Gerard Espinosa, José Hernández‐Rodríguez, et al.
Lupus (2025)
Closed Access
Medication-related hospitalisations in patients with SLE
Michèle Stanciu, J. Lee, Emily G. McDonald, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001362-e001362
Open Access
LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials
Eric F. Morand, Ronald van Vollenhoven, Richard Furie, et al.
Annals of the Rheumatic Diseases (2025)
Closed Access

Scroll to top